Live Earnings Conference Call: Karyopharm Therapeutics will host a live Q2 2025 earnings call on August 11, 2025 at 8:00AM ET. Follow this link to get details and listen to Karyopharm Therapeutics' Q2 2025 earnings call when it goes live. Get details. Karyopharm Therapeutics (KPTI) News Today $3.94 -0.03 (-0.76%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$4.00 +0.06 (+1.40%) As of 08/8/2025 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KPTI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Report Preview: What To ExpectAugust 10 at 2:38 AM | finance.yahoo.comEarnings Outlook For Karyopharm TherapeuticsAugust 8 at 4:43 PM | benzinga.comKaryopharm to Report Second Quarter 2025 Financial Results on August 11, 2025August 5, 2025 | prnewswire.comKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | prnewswire.comJPMorgan Chase & Co. Expands Stake in Karyopharm Therapeutics Inc.July 22, 2025 | gurufocus.comHC Wainwright & Co. Downgrades Karyopharm Therapeutics (KPTI)July 16, 2025 | msn.comKaryopharm stock tumbles after disclosing failed financing talksJuly 11, 2025 | investing.comKaryopharm Shares Slide After Financing Efforts Stall, Strategic Review UnderwayJuly 11, 2025 | msn.comKaryopharm to Cut About 20% of Workforce Amid Ongoing ReviewJuly 11, 2025 | marketwatch.comKaryopharm Therapeutics Inc News (KPTI) - Investing.comJuly 2, 2025 | investing.comKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 1, 2025 | prnewswire.comKaryopharm to Present at the Jefferies Global Healthcare ConferenceJune 3, 2025 | prnewswire.comKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 2, 2025 | prnewswire.comKaryopharm to Participate at the 2025 RBC Capital Markets Global Healthcare ConferenceMay 19, 2025 | prnewswire.comRobert W. Baird Issues Pessimistic Forecast for Karyopharm Therapeutics (NASDAQ:KPTI) Stock PriceMay 15, 2025 | marketbeat.comKaryopharm Therapeutics (NASDAQ:KPTI) Posts Earnings Results, Beats Estimates By $1.44 EPSMay 14, 2025 | marketbeat.comKaryopharm Announces Poster Presentation on Selinexor in Myelofibrosis at the 2025 European Hematology Association Annual MeetingMay 14, 2025 | prnewswire.comKaryopharm Reports First Quarter 2025 Financial Results and Announces New Data in Myelofibrosis that Further Suggests Selinexor May Lead to Meaningful Spleen Volume Reduction, Symptom Improvement, Hemoglobin Stabilization and Disease ModificationMay 12, 2025 | prnewswire.comKaryopharm Therapeutics (KPTI) to Release Earnings on WednesdayMay 9, 2025 | marketbeat.comKaryopharm Therapeutics (NASDAQ:KPTI) Stock Price Passes Below 200 Day Moving Average - Here's WhyMay 9, 2025 | marketbeat.comKaryopharm to Report First Quarter 2025 Financial Results on May 12, 2025May 8, 2025 | prnewswire.comKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 1, 2025 | prnewswire.comKaryopharm Therapeutics Inc.DL-Exch. Notes 2018(25) BondMay 1, 2025 | markets.businessinsider.comKaryopharm Therapeutics (NASDAQ:KPTI) Shares Cross Below 200-Day Moving Average - Here's WhyApril 30, 2025 | marketbeat.comKaryopharm Therapeutics Inc. Common Stock (KPTI)April 23, 2025 | nasdaq.comKaryopharm Therapeutics Inc. Common Stock (KPTI)April 23, 2025 | nasdaq.comKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 1, 2025 | prnewswire.comKaryopharm Therapeutics (NASDAQ:KPTI) Stock Crosses Below 200-Day Moving Average - Here's What HappenedMarch 25, 2025 | marketbeat.comKaryopharm price target lowered to split-adjusted $15 from $75 at Piper SandlerMarch 20, 2025 | markets.businessinsider.comKaryopharm Therapeutics (KPTI) Receives a Buy from Piper SandlerMarch 20, 2025 | markets.businessinsider.comKaryopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Down 23.7% in FebruaryMarch 18, 2025 | marketbeat.comKaryopharm Therapeutics (NASDAQ:KPTI) Shares Cross Below 200-Day Moving Average - Time to Sell?March 11, 2025 | marketbeat.comXPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene's Commercial Presence in APACMarch 4, 2025 | prnewswire.comKaryopharm price target lowered to $54 from $75 at BairdMarch 3, 2025 | markets.businessinsider.comKaryopharm Therapeutics (NASDAQ:KPTI) Given New $54.00 Price Target at Robert W. BairdMarch 3, 2025 | marketbeat.comQ1 EPS Estimate for Karyopharm Therapeutics Cut by AnalystMarch 3, 2025 | marketbeat.comKaryopharm Therapeutics Inc.'s SWOT analysis: biotech firm's stock faces pivotal yearFebruary 28, 2025 | uk.investing.comKaryopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Down 93.1% in FebruaryFebruary 28, 2025 | marketbeat.comKaryopharm Therapeutics (NASDAQ:KPTI) Stock Price Down 9% - What's Next?February 28, 2025 | marketbeat.comKaryopharm Therapeutics (KPTI) to Release Quarterly Earnings on ThursdayFebruary 27, 2025 | marketbeat.comKaryopharm trading halted, news pendingFebruary 26, 2025 | markets.businessinsider.comKaryopharm target adjusted to $7 from $56 at H.C. WainwrightFebruary 26, 2025 | markets.businessinsider.comKaryopharm Therapeutics (NASDAQ:KPTI) Sees Strong Trading Volume Following Analyst UpgradeFebruary 26, 2025 | marketbeat.comHC Wainwright Issues Positive Forecast for Karyopharm Therapeutics (NASDAQ:KPTI) Stock PriceFebruary 26, 2025 | marketbeat.comKaryopharm Therapeutics Inc.: Karyopharm Announces 1-for-15 Reverse Stock SplitFebruary 24, 2025 | finanznachrichten.deKaryopharm implementing 1-for-15 reverse stock splitFebruary 24, 2025 | markets.businessinsider.comKaryopharm Announces 1-for-15 Reverse Stock SplitFebruary 24, 2025 | prnewswire.comLeerink Partnrs Has Pessimistic View of KPTI FY2025 EarningsFebruary 24, 2025 | marketbeat.comResearch Analysts Offer Predictions for KPTI Q1 EarningsFebruary 24, 2025 | marketbeat.comAnalysts Set Expectations for KPTI Q1 EarningsFebruary 22, 2025 | marketbeat.com Get Karyopharm Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KPTI and its competitors with MarketBeat's FREE daily newsletter. Email Address KPTI Media Mentions By Week KPTI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KPTI News Sentiment▼0.000.48▲Average Medical News Sentiment KPTI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KPTI Articles This Week▼32▲KPTI Articles Average Week Get Karyopharm Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KPTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genelux News Today Compugen News Today Korro Bio News Today Spero Therapeutics News Today BioHarvest Sciences News Today Fate Therapeutics News Today Seres Therapeutics News Today Immuneering News Today Protalix BioTherapeutics News Today Inhibikase Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KPTI) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karyopharm Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Karyopharm Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale